HIGH SENSITIVITY TROPONIN ASSAY FOR EARLY DIAGNOSIS OF ACUTE CORONARY SYNDROME IN A REAL-WORLD SITUATION: COMPARISON BETWEEN HS-TNT, LOCI HS-TNI, HS-TNI ROCHE AND CONVENTIONAL TNT.  by Biasillo, Gina et al.
A118.E1106
JACC March 9, 2010
Volume 55, issue 10A
 MYOCARDIAL ISCHEMIA AND INFARCTION 
HIGH SENSITIVITY TROPONIN ASSAY FOR EARLY DIAGNOSIS OF ACUTE CORONARY SYNDROME 
IN A REAL-WORLD SITUATION: COMPARISON BETWEEN HS-TNT, LOCI HS-TNI, HS-TNI ROCHE AND 
CONVENTIONAL TNT.
ACC Poster Contributions
Georgia World Congress Center, Hall B5
Monday, March 15, 2010, 3:30 p.m.-4:30 p.m.
Session Title: Evolution of Troponin Testing in Acute Coronary Syndromes
Abstract Category: Unstable Ischemic Syndrome--Clinical
Presentation Number: 1208-257
Authors: Gina Biasillo, Luigi M. Biasucci, Roberta Della Bona, Ilaria Dato, Milena Leo, Massimo Gustapane, Maria T. Cardillo, Antonella Stefanelli, 
Pio Cialdella, Andrea Silenzi, Giulia Pignataro, Niccolò Gentiloni Silveri, Martina Zaninotto, Mario Plebani, Filippo Crea, Catholic University of Sacred 
Heart, Rome, Italy, Hospital University, Padua, Italy
Background: Proper management of chest pain in Emergency Department (ED) represents a challenging clinical problem. Among different 
biomarkers assessed for diagnostic purpose, cardiac troponin is central to the diagnosis of acute myocardial infarction. The use of new assays 
promises a higher sensitivity for Acute Coronary Syndrome (ACS) among patients (pts) admitted to ED with a shorter time to positivity of the test. We 
evaluated three different high-sensitivity Troponin I and T assays for early diagnosis of ACS.
Methods: 244 pts admitted to ED because of chest pain were enrolled. Serum levels of TnT, high sensitivity Troponin T (hs-TnT) and two type of high 
sensitivity Troponin I assays (LOCI hs-TnI, hs-TnI Roche) were measured from baseline samples. ECG and previous history of ACS were obtained in 
all pts. Diagnostic accuracy of biomarkers was evaluated by constructing Receiver-Operating Characteristic (ROC) curve and calculating Area Under 
Curve (AUC).
Results: Nineteen pts (7% of overall population) were discharged with a diagnosis of ACS according to current guidelines. Diagnostic accuracy was 
similar among the different test: AUC=0,911 for TnT (sensitivity 0,895; specificity 0,929); AUC=0,878 for hs-TnT (sensitivity 0,947; specificity 0,809); 
AUC= 0,864 for LOCI hs-TnI (sensitivity 0,789; specificity 0,938); AUC=0,877 for hs-TnI Roche (sensitivity 0,789; specificity 0,964).
Conclusions: In a real-world situation of ED, with low prevalence of ACS, high sensitivity Troponin T and I assays does not improve discrimination for 
the early diagnosis of ACS, in comparison with conventional TnT. This might also be due to the large proportion of pts (>50%) that had a time from 
symptoms onset to blood sampling longer than 5 hours. Long time elapsing between pain onset and admission to ED could reduce the advantage of 
high-sensitivity Troponins.
